(Q43264237)

English

Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

scientific article published on 7 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 November 2017

Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

17 November 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Charcot-Marie-Tooth disease type 1A

1 reference

based on heuristic

inferred from title

Elisabeth Jouve

object named as

Elisabeth Jouve

8

1 reference

ORCID Public Data File 2021

author name string

Joëlle Micallef

1

1 reference

Europe PubMed Central

17 November 2017

Shahram Attarian

2

1 reference

Europe PubMed Central

17 November 2017

Odile Dubourg

3

1 reference

Europe PubMed Central

17 November 2017

Pierre-Marie Gonnaud

4

1 reference

Europe PubMed Central

17 November 2017

Jean-Yves Hogrel

5

1 reference

Europe PubMed Central

17 November 2017

Tanya Stojkovic

6

1 reference

Europe PubMed Central

17 November 2017

Rafaelle Bernard

7

1 reference

Europe PubMed Central

17 November 2017

Severine Pitel

9

1 reference

Europe PubMed Central

17 November 2017

Francois Vacherot

10

1 reference

Europe PubMed Central

17 November 2017

Jean-Francois Remec

11

1 reference

Europe PubMed Central

17 November 2017

Laurent Jomir

12

1 reference

Europe PubMed Central

17 November 2017

Eric Azabou

13

1 reference

Europe PubMed Central

17 November 2017

Mahmoud Al-Moussawi

14

1 reference

Europe PubMed Central

17 November 2017

Marie-Noelle Lefebvre

15

1 reference

Europe PubMed Central

17 November 2017

Laurence Attolini

16

1 reference

Europe PubMed Central

17 November 2017

Sadek Yaici

17

1 reference

Europe PubMed Central

17 November 2017

Daniel Tanesse

18

1 reference

Europe PubMed Central

17 November 2017

Michel Fontes

19

1 reference

Europe PubMed Central

17 November 2017

Jean Pouget

20

1 reference

Europe PubMed Central

17 November 2017

Olivier Blin

21

1 reference

Europe PubMed Central

17 November 2017

publication date

7 October 2009

1 reference

Europe PubMed Central

17 November 2017

Lancet Neurology

1 reference

Europe PubMed Central

17 November 2017

8

1 reference

Europe PubMed Central

17 November 2017

12

1 reference

Europe PubMed Central

17 November 2017

1103-1110

1 reference

Europe PubMed Central

17 November 2017

Genetic and clinical aspects of Charcot-Marie-Tooth's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA duplication associated with Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Charcot-Marie-Tooth Disease Type 1A -- Association with a Spontaneous Point Mutation in the PMP22 Gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dominantly inherited peripheral neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

PMP22 overexpression causes dysmyelination in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A transgenic rat model of Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ascorbic acid inhibits PMP22 expression by reducing cAMP levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new functions?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamins E and C are safe across a broad range of intakes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability and validity of the CMT neuropathy score as a measure of disability.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathy progression in Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

CMT1X phenotypes represent loss of GJB1 gene function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a French isometric strength normative database for adults using quantitative muscle testing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ascorbic acid for treatment of CMT1A: the jury is still out.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of CMT1A including QoL: A 2-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970260-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(09)70260-1

1 reference

Europe PubMed Central

17 November 2017

1 reference

Europe PubMed Central

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43264237&oldid=1985094689"